Therefore, DNAJC3-AS1 may regulate the expression of ACC1/FASN via the EGFR/PI3K/AKT/NF-Kb/SREBP1 pathway to promote the progression of CRC. This evidence concerns the gene EGFR and colorectal carcinoma.